11TH SEMI-ANNUAL DIAGNOSTIC COVERAGE AND REIMBURSEMENT CONFERENCE EAST

DECEMBER 4-5, 2017 | CAMBRIDGE, MA

HYATT REGENCY CAMBRIDGE

Download AgendaRegister Now

Special Thanks to Our Sponsors

Aligning Payer Networks’ Specific Needs with Diagnostic Development to Facilitate Expedited Reimbursement & Access to Alternate Payment Models, Focus on Clinical Study Design Enabling Generation of Actionable Evidence & Highlighting Clinical Utility, while Advancing on Value Based Care & Risk Sharing Applied to Diagnostics

Throughout the diagnostics industry, organizations strive to develop and market the most accurate tests ranging all therapeutic indications and diseases, to significantly improve patient treatments and lives. With tightening healthcare budgets, reimbursement of diagnostics is granted only to the most relevant products that address unmet or under-represented patient populations, or that enable better patient outcomes than existing tests. Robust evidence of product value from the scientific standpoint must be generated through thorough testing in the clinical environment, as well as economic evidence highlighting the test’s positive impact in the patient’s overall treatment plan. It is therefore critical for diagnostic reimbursement professionals to clearly understand payer evidence expectations in addition to which products can fit current health plans and networks to secure reimbursement in a timely manner.

For the 11th edition of the Q1 Diagnostic Coverage & Reimbursement Conference, focus is set on defining value of diagnostics and evidence to demonstrate clinical utility and cost benefits from the payer’s perspective, in addition to accessing promising partnerships with insurers through alternate payment models, paving the way to satisfactory and expedited reimbursement. Through insightful case studies delivered by high level industry thought leaders but also panel and round table discussions involving payer organization coverage decision makers, the event will once more shed light onto solutions for critical areas of challenges in obtaining positive reimbursement with the most relevant strategies to further advance accurate testing in the healthcare market.

ej_thumbContact:

Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | marketing@q1productions.com

Share This